Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT03866460
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent indicating awareness of the investigational nature of the protocol.
* Children with RB aged 3 months and older who are scheduled to receive their first dose of IA carboplatin chemotherapy.
* Retinoblastoma is rarely seen in children over 8 years old, however we will not include an upper age range so as not to exclude any possible participants
Exclusion Criteria:
* Children with known and documented preexisting hearing loss.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Months
Maximum Age:
18 Years
Study:
NCT03866460
Study Brief:
Protocol Section:
NCT03866460